CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Retained Earnings
Balance at Dec. 31, 2022	$ 1,910,700	$ 556	$ 1,547,266	$ (34,394)	$ 397,272
Beginning Balance (in shares) at Dec. 31, 2022		55,557,698
Net Income (Loss)	28,829				28,829
Exercise of stock options and vesting of stock units	29	$ 1	28
Exercise of stock options and vesting of stock units (in shares)		140,210
Tax withholding on vesting of restricted stock units	(9,593)	$ (1)	(9,592)
Tax withholding on vesting of restricted stock units (in shares)		(53,607)
Stock-based compensation expense	7,254		7,254
Balance at Mar. 31, 2023	1,940,492	$ 556	1,544,956	(31,121)	426,101
Ending Balance (in shares) at Mar. 31, 2023		55,644,301
Translation adjustment	3,273			3,273
Balance at Dec. 31, 2023	1,971,203	$ 558	1,569,227	(37,431)	438,849
Beginning Balance (in shares) at Dec. 31, 2023		55,766,078
Net Income (Loss)	2,094				2,094
Exercise of stock options and vesting of stock units	945	$ 1	944
Exercise of stock options and vesting of stock units (in shares)		111,921
Tax withholding on vesting of restricted stock units	(7,622)	$ 0	(7,622)
Tax withholding on vesting of restricted stock units (in shares)		(39,451)
Issuance of common stock pursuant to contingent consideration earnout payment	541	$ 0	541
Issuance of common stock pursuant to contingent consideration earnout payment (in shares)		2,770
Conversion of debt	(55)		(55)
Stock-based compensation expense	8,776		8,776
Balance at Mar. 31, 2024	1,970,601	$ 559	$ 1,571,811	(42,712)	$ 440,943
Ending Balance (in shares) at Mar. 31, 2024		55,841,318
Translation adjustment	$ (5,281)			$ (5,281)